INS and Hepatic steatosis: Previous studies reported that impaired insulin action is a step preceding the induction of T2D and comorbidities such as abdominal obesity, hyperlipidemia, hepatic steatosis, PCOS, increased blood pressure, and cardiovascular disease [16,50,52].